Literature DB >> 21348958

Microfluidics for T- lymphocyte cell separation and inflammation monitoring in burn patients.

Alan E Rosenbach1, Piyush Koria, Jeremy Goverman, Kenneth T Kotz, Amit Gupta, Ming Yu, Shawn P Fagan, Daniel Irimia, Ronald G Tompkins.   

Abstract

Severe burns result in T lymphocyte specific immunologic changes. In addition to decreased levels of circulating lymphocytes, changes in cytokine secretion and receptor expression also take place. Our finer understanding of the inflammatory response has led to the development of immune-targeted therapeutics, requiring specialized gene-expression monitoring. The emerging field of bio-micro-electromechanical systems can be used to isolate highly pure T lymphocytes in a clinically relevant and timely manner for downstream genomic analysis. Blood samples from healthy volunteers and burn-injured patients were introduced into microfluidic devices developed in our laboratory. Utilizing cell-affinity chromatography for positive selection of T lymphocytes, the devices served as a platform for RNA extraction and downstream cytokine analysis via quantitative real-time polymerase chain reaction (PCR). From a 0.5-mL whole blood sample, the microfluidic devices captured highly pure T lymphocytes from healthy volunteers and burn-injured patients. Cell capture was of sufficient quantity, and extracted RNA was of sufficient quality, for evaluating the gene expression of cytokines: interferon-gamma, interleukin-2, interleukin-4, and interleukin-10. Microfluidics is a useful tool in processing blood from burn-injured patients. Though in its very early stages of development, cell-specific information obtained by this platform/technology will likely be an important component of near-patient molecular diagnostics and personalized medicine.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21348958      PMCID: PMC3057059          DOI: 10.1111/j.1752-8062.2010.00255.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  20 in total

Review 1.  Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

Authors:  Gillian M Keating; Caroline M Perry
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 2.  An overview of real-time quantitative PCR: applications to quantify cytokine gene expression.

Authors:  A Giulietti; L Overbergh; D Valckx; B Decallonne; R Bouillon; C Mathieu
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction.

Authors:  A Lyons; A Goebel; J A Mannick; J A Lederer
Journal:  Arch Surg       Date:  1999-12

4.  Design and construction of a linear shear stress flow chamber.

Authors:  S Usami; H H Chen; Y Zhao; S Chien; R Skalak
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

5.  Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: comparison of ELISPOT, a novel ELISA and real-time RT-PCR.

Authors:  Christina Ekerfelt; Jan Ernerudh; Maria C Jenmalm
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

6.  Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array.

Authors:  Violeta Rus; Sergei P Atamas; Valentina Shustova; Irina G Luzina; Florin Selaru; Laurence S Magder; Charles S Via
Journal:  Clin Immunol       Date:  2002-03       Impact factor: 3.969

7.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Authors:  Lars Bullinger; Konstanze Döhner; Eric Bair; Stefan Fröhling; Richard F Schlenk; Robert Tibshirani; Hartmut Döhner; Jonathan R Pollack
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

8.  Quantification of cytokine gene expression using an economical real-time polymerase chain reaction method based on SYBR Green I.

Authors:  R Ramos-Payán; M Aguilar-Medina; S Estrada-Parra; J A González-Y-Merchand; L Favila-Castillo; A Monroy-Ostria; I C E Estrada-Garcia
Journal:  Scand J Immunol       Date:  2003-05       Impact factor: 3.487

9.  Disease-modifying therapy in multiple sclerosis: update and clinical implications.

Authors:  Douglas S Goodin
Journal:  Neurology       Date:  2008-12-09       Impact factor: 9.910

10.  Insulin-like growth factor-I/insulin-like growth factor binding protein-3 alters lymphocyte responsiveness following severe burn.

Authors:  Steven E Wolf; Kenneth J Woodside; Roque J Ramirez; Makiko Kobayashi; Fujio Suzuki; David N Herndon
Journal:  J Surg Res       Date:  2004-04       Impact factor: 2.192

View more
  4 in total

1.  Genomics of injury: The Glue Grant experience.

Authors:  Ronald G Tompkins
Journal:  J Trauma Acute Care Surg       Date:  2015-04       Impact factor: 3.313

2.  Enabling systems biology approaches through microfabricated systems.

Authors:  Mei Zhan; Loice Chingozha; Hang Lu
Journal:  Anal Chem       Date:  2013-10-01       Impact factor: 6.986

3.  Smart interface materials integrated with microfluidics for on-demand local capture and release of cells.

Authors:  Umut Atakan Gurkan; Savas Tasoglu; Derya Akkaynak; Oguzhan Avci; Sebnem Unluisler; Serli Canikyan; Noah Maccallum; Utkan Demirci
Journal:  Adv Healthc Mater       Date:  2012-07-09       Impact factor: 9.933

4.  Comparison of whole blood and peripheral blood mononuclear cell gene expression for evaluation of the perioperative inflammatory response in patients with advanced heart failure.

Authors:  Galyna Bondar; Martin Cadeiras; Nicholas Wisniewski; Jetrina Maque; Jay Chittoor; Eleanor Chang; Maral Bakir; Charlotte Starling; Khurram Shahzad; Peipei Ping; Elaine Reed; Mario Deng
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.